Mark Jacobs
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Atrial Fibrillation Management and Outcomes 4
- Cardiac pacing and defibrillation studies 2
- Cardiac, Anesthesia and Surgical Outcomes 1
- Surgery 2
- Heparin-Induced Thrombocytopenia and Thrombosis 1
- Co-authors
- Walter Fiedler (2 shared papers)Wolfgang E. Berdel (2 shared papers)P. Scigalla (2 shared papers)Hubert Serve (2 shared papers)A O’Farrell (2 shared papers)Steven Noel (1 shared paper)Ron Paquette (1 shared paper)Maureen Cooper (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Circulation (2 papers)European Heart Journal (1 paper)JACC Heart Failure (1 paper)Blood (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark Jacobs
13 papers receiving 661 citations
Peers
Comparison fields: 5 of 68
- Hematology 311
- Genetics 127
- Internal Medicine 31
- Cardiology and Cardiovascular Medicine 112
- Cancer Research 63
Countries citing papers authored by Mark Jacobs
This map shows the geographic impact of Mark Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jacobs more than expected).
Fields of papers citing papers by Mark Jacobs
This network shows the impact of papers produced by Mark Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jacobs. The network helps show where Mark Jacobs may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients. | 2003 | 270 |
| 2 | 2003 | 222 | |
| 3 | 2016 | 117 | |
| 4 | 2006 | 68 | |
| 5 | 2007 | 7 | |
| 6 | Speakeasy Studio and Cafe: Information Literacy, Web-based Library Instruction, and Technology. | 2001 | 6 |
| 7 | 2024 | 2 | |
| 8 | 2020 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2007 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2005 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2024 | 0 | |
| 17 | 2022 | 0 | |
| 18 | 2023 | 0 | |
| 19 | Introducing a Directory Service | 1995 | 0 |
About Mark Jacobs
Mark Jacobs is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Information Systems, Internal Medicine and Oncology, having authored 19 papers that have together received 698 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Cardiac pacing and defibrillation studies (2 papers), Mechanical Circulatory Support Devices (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Infective Endocarditis Diagnosis and Management (2 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Heparin-Induced Thrombocytopenia and Thrombosis (1 paper). The work is most often cited by research in Hematology (311 citations), Genetics (127 citations), Internal Medicine (31 citations), Cardiology and Cardiovascular Medicine (112 citations) and Cancer Research (63 citations). Mark Jacobs has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Walter Fiedler, Wolfgang E. Berdel, P. Scigalla, Hubert Serve, A O’Farrell, Steven Noel, Ron Paquette, Maureen Cooper, James M. Foran and Michael C. Heinrich. Their work appears in journals such as Journal of Clinical Oncology, Circulation, European Heart Journal, JACC Heart Failure and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.